Brief: Sensei Biotherapeutics Provides Corporate Update And Upcoming Milestones

Faeth Therapeutics,

04/01/2024 12:44

Jan 4 (Reuters) - Sensei Biotherapeutics Inc  SNSE.O :
    * SENSEI BIOTHERAPEUTICS PROVIDES CORPORATE UPDATE AND
HIGHLIGHTS
KEY UPCOMING MILESTONES
    * REALIGNMENT OF RESOURCES IS EXPECTED TO EXTEND CASH RUNWAY
INTO
Q4 OF 2025
    * TOPLINE DATA FOR SNS-101 MONOTHERAPY DOSE ESCALATION ARM
IN Q2
2024
    * TOPLINE DATA FOR COMBINATION DOSE ESCALATION ARM OF
SNS-101 AND
LIBTAYO IN Q3 2024
    * INITIAL DATA FOR SNS-101 DOSE EXPANSION COHORTS BY END OF
2024

Source text for Eikon:  ID:nGNXbhR8lw 
Further company coverage:  SNSE.O 

 ((Reuters.Briefs@thomsonreuters.com;))